v3.22.2.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 846 $ 767 $ 3,525 $ 1,938
General and administrative 1,315 628 4,255 1,377
Total operating expenses 2,161 1,395 7,780 3,315
Loss from operations (2,161) (1,395) (7,780) (3,315)
Interest income (expense), net 22 (208) 43 (835)
Other income, net 3 170 4 119
(Loss) gain on loan extinguishment (78) 62
Total other income (expenses), net 25 (116) 47 (654)
Net loss (2,136) (1,511) (7,733) (3,969)
Other comprehensive income:        
Unrealized gain on marketable securities 17 13
Comprehensive income $ (2,119) $ (1,511) $ (7,720) $ (3,969)
Net loss per share, basic and diluted $ (0.24) $ (0.27) $ (0.86) $ (1.09)
Weighted-average shares of common stock outstanding, basic and diluted 9,067,509 5,620,135 9,039,308 3,640,988

Source